
## Plasma proteome variation and its genetic determinants in children and adolescents

Discovery and replication cohorts

Impact of demographic and health factors on plasma proteome

Effect of SNPs on the plasma proteome

Decomposition of variance in plasma protein levels

Characterization of pQTL effect sizes

Integrating pQTLs with variant–trait associations

Highly replicated pQTLs in children and adults



## Proteomic landscape of epithelial ovarian cancer

A proteomic landscape of Chinese EOCs

Malignancy-associated proteins in EOC tissue and plasma samples

Proteomic features among five histological subtypes of Chinese EOC

Proteins potentially correlated with prognosis of advanced HGSOC

Characterizing prognostic plasma proteins of primary HGSOC patients

Protein classifiers for prognosis prediction

Divergent DNA Damage Response in HGSOC: Primary vs. Relapsed


## Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions

Deep coverage of serum proteomes through circulating EVs analysis

Establishing a workflow for proteomics of serum SEV and LEV-enriched fractions

Application of the workflow for proteomics of serum SEV and LEV enriched fraction to study OAPS

## Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy

Cohort characteristics and research design

Plasma proteome revealed negative linkage between cholesterol metabolism and oncogenic signaling after DBT

Thyroid hormone related clinical indicators are significantly altered by DBT

Integrated analysis of proteome and radiology imaging reveals the potential of APOC3 as a biomarker in the DBT response

Integrated proteome-clinical features-based machine learning model provide an accurate measure for DBT



## Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction

Patients included in the study

Overall architecture of pediatric SARS-CoV-2 and MIS-C plasma proteome

Characterizing pathways of activation in patients with MIS-C and SARS-CoV-2 infection

MIS-C is characterized by a disproportionate response to interferon gamma

MIS-C patients have an MAS-like phenotype characterized by IFNγ and CXCL9 signaling

PLA2G2A is a candidate biomarker for MIS-C and is associated with a thrombotic microangiopathy phenotype

Clinical heterogeneity among MIS-C patients


## Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in children

Plasma proteins in children with MIS-C compared to controls

Diagnostic classifier for MIS-C using machine learning

Validation of the 4-protein diagnostic signature


## New biomarkers of Kawasaki disease identified by gingival crevicular fluid proteomics

Finally, MRM-MS confirmed the expression patterns of 12 DEPs (IFIT3, UB2L6, HP, A1AT, HSP90AA1, HNRPC, HSP90AB1, SAA1, MX1, B2M FKBP4, and TRAP1), thereby demonstrating high consistency with the DIA results and further validating the DEPs’ potential as biomarkers for KD.

